Craniosynostosis-associated Fgfr2C342Y mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Liu, J ^a   Kwon, T G ^b   Nam, H K ^a   Hatch, N E ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MASS; BONE MATRIX; BONE MINERALIZATION; CELL CULTURE; CELL ISOLATION; CELL MUTANT; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CORTICAL BONE; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LONG BONE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; STROMA CELL; ANIMAL; BONE; BONE DEVELOPMENT; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MUTATION; NUDE MOUSE; ORGAN SIZE; PATHOLOGY; RADIOGRAPHY; STAINING; SUBCUTANEOUS TISSUE;

MUS;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CRANIOSYNOSTOSES; GENE EXPRESSION REGULATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; MUTATION; ORGAN SIZE; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; STAINING AND LABELING; SUBCUTANEOUS TISSUE; X-RAY MICROTOMOGRAPHY;

EID: 84878678344     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/292506     Document Type: Article

References (59)

1. Renier D., Lajeunie E., Arnaud E., Marchac D., Management of craniosynostoses. Child's Nervous System 2000 16 10-11 645 658 2-s2.0-0033647448 10.1007/s003810000320
2. Seruya M., Oh A., Boyajian M. J., Posnick J. C., Keating R. F., Treatment for delayed presentation of sagittal synostosis: challenges pertaining to occult intracranial hypertension-clinical article. Journal of Neurosurgery 2011 8 1 40 48 2-s2.0-79960236159 10.3171/2011.4.PEDS1160
3. Morriss-Kay G. M., Wilkie A. O. M., Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. Journal of Anatomy 2005 207 5 637 653 2-s2.0-28444453646 (Pubitemid 41723374)
4. Kreiborg S., Craniofacial growth in plagiocephaly and Crouzon syndrome. Scandinavian Journal of Plastic and Reconstructive Surgery 1981 15 3 187 197 2-s2.0-0019725137 (Pubitemid 12085841)
5. C342Y mutation are cranial bone dependent. Calcified Tissue International 2013 92 5 451 466 10.1007/s00223-013-9701-2
6. Okajima K., Robinson L. K., Hart M. A., Abuelo D. N., Cowan L. S., Hasegawa T., Maumenee I. H., Jabs E. W., Ocular anterior chamber dysgenesis in craniosynostosis syndromes with a fibroblast growth factor receptor 2 mutation. American Journal of Medical Genetics 1999 85 2 160 170 (Pubitemid 29288342)
7. Stavrou P., Sgouros S., Willshaw H. E., Goldin J. H., Hockley A. D., Wake M. J. C., Visual failure caused by raised intracranial pressure in craniosynostosis. Child's Nervous System 1997 13 2 64 67 2-s2.0-0030970059 10.1007/s003810050043 (Pubitemid 27132697)
8. Abe H., Ikota T., Akino M., Kitami K., Tsuru M., Functional prognosis of surgical treatment of craniosynostosis. Child's Nervous System 1985 1 1 53 61 2-s2.0-0022261069 (Pubitemid 15020992)
9. Shah P. S., Siriwardena K., Taylor G., Steele L., Ray P., Blaser S., Chitayat D., Sudden infant death in a patient with FGFR3 P250R mutation. American Journal of Medical Genetics A 2006 140 24 2794 2796 2-s2.0-33845248213 10.1002/ajmg.a.31517 (Pubitemid 44865066)
10. Cohen M. M., Kreiborg S., Upper and lower airway compromise in the Apert syndrome. American Journal of Medical Genetics 1992 44 1 90 93 2-s2.0-0026646704
11. Rasmussen S. A., Yazdy M. M., Frías J. L., Honein M. A., Priorities for public health research on craniosynostosis: summary and recommendations from a Centers for Disease Control and Prevention-sponsored meeting. American Journal of Medical Genetics A 2008 146 2 149 158 2-s2.0-37849027250 10.1002/ajmg.a.32106
12. Williams J. K., Cohen S. R., Burstein F. D., Hudgins R., Boydston W., Simms C., A longitudinal, statistical study of reoperation rates in craniosynostosis. Plastic and Reconstructive Surgery 1997 100 2 305 310 2-s2.0-0030670696 10.1097/00006534-199708000-00003 (Pubitemid 27458762)
13. Reardon W., Winter R. M., Rutland P., Pulleyn L. J., Jones B. M., Malcolm S., Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genetics 1994 8 1 98 103 2-s2.0-0027981524 10.1038/ng0994-98 (Pubitemid 24274068)
14. Schell U., Hehr A., Feldman G. J., Robin N. H., Zackai E. H., De Die-Smulders C., Viskochil D. H., Stewart J. M., Wolff G., Ohashi H., Price R. A., Cohen M. M., Muenke M., Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Human Molecular Genetics 1995 4 3 323 328 2-s2.0-0028930046
15. Wilkie A. O. M., Slaney S. F., Oldridge M., Poole M. D., Ashworth G. J., Hockley A. D., Hayward R. D., David D. J., Pulleyn L. J., Rutland P., Malcolm S., Winter R. M., Reardon W., Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genetics 1995 9 2 165 172 2-s2.0-0028798546
16. Ibrahimi O. A., Zhang F., Eliseenkova A. V., Linhardt R. J., Mohammadi M., Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Human Molecular Genetics 2004 13 1 69 78 2-s2.0-0347287038 10.1093/hmg/ddh011 (Pubitemid 38072136)
17. Hatch N. E., FGF signaling in craniofacial biological control and pathological craniofacial development. Critical Reviews in Eukaryotic Gene Expression 2010 20 4 295 311 2-s2.0-79955002353
18. Andersen J., Burns H. D., Enriquez-Harris P., Wilkie A. O. M., Heath J. K., Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Human Molecular Genetics 1998 7 9 1475 1483 2-s2.0-0031683688 10.1093/hmg/7.9.1475 (Pubitemid 28429929)
19. Yu K., Herr A. B., Waksman G., Ornitz D. M., Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14536 14541 2-s2.0-0034687699 10.1073/pnas.97.26.14536 (Pubitemid 32016611)
20. Neilson K. M., Friesel R. E., Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. Journal of Biological Chemistry 1995 270 44 26037 26040 2-s2.0-0028846512 10.1074/jbc.270.44.26037
21. Shukla V., Coumoul X., Wang R. H., Kim H. S., Deng C. X., RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nature Genetics 2007 39 9 1145 1150 2-s2.0-34548371795 10.1038/ng2096 (Pubitemid 47340648)
22. Eswarakumar V. P., Özcan F., Lew E. D., Bae J. H., Tomé F., Booth C. J., Adams D. J., Lax I., Schlessinger J., Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 49 18603 18608 2-s2.0-33845475612 10.1073/pnas.0609157103 (Pubitemid 44913457)
23. Cooper G. M., Durham E. L., Cray J. J., Siegel M. I., Losee J. E., Mooney M. P., Tissue interactions between craniosynostotic dura mater and bone. Journal of Craniofacial Surgery 2012 23 3 919 924
24. Ang B. U., Spivak R. M., Nah H. D., Kirschner R. E., Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts. Journal of Craniofacial Surgery 2010 21 2 462 467 2-s2.0-77952871270 10.1097/SCS.0b013e3181cfe9a0
25. Slater B. J., Kwan M. D., Gupta D. M., Amasha R. R., Wan D. C., Longaker M. T., Dissecting the influence of regional dura mater on cranial suture biology. Plastic and Reconstructive Surgery 2008 122 1 77 84 2-s2.0-48049092833 10.1097/PRS.0b013e318177478c
26. Mangasarian K., Li Y., Mansukhani A., Basilico C., Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. Journal of Cellular Physiology 1997 172 1 117 125 (Pubitemid 27283354)
27. Lomri A., Lemonnier J., Hott M., De Parseval N., Lajeunie E., Munnich A., Renier D., Marie P. J., Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. Journal of Clinical Investigation 1998 101 6 1310 1317 2-s2.0-0032521181 (Pubitemid 28145247)
28. Holmes G., Rothschild G., Roy U. B., Deng C. X., Mansukhani A., Basilico C., Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Developmental Biology 2009 328 2 273 284 2-s2.0-63349106487 10.1016/j.ydbio.2009.01.026
29. Online Mendelian Inheritance in Man, OMIM, MIM Number 123500 Baltimore, Md, USA Johns Hopkins University. 2011, http://omim.org/entry/123500
30. Kreiborg S., Crouzon Syndrome. A clinical and roentgencephalometric study. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 1981 18 1 198
31. Proudman T. W., Moore M. H., Abbott A. H., David D. J., Noncraniofacial manifestations of Crouzon's disease. Journal of Craniofacial Surgery 1994 5 4 218 222 (Pubitemid 24310513)
32. Eswarakumar V. P., Horowitz M. C., Locklin R., Morriss-Kay G. M., Lonai P., A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proceedings of the National Academy of Sciences of the United States of America 2004 101 34 12555 12560 2-s2.0-4344689004 10.1073/pnas.0405031101 (Pubitemid 39122062)
33. Pampaloni F., Reynaud E. G., Stelzer E. H. K., The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology 2007 8 10 839 845 2-s2.0-34648834682 10.1038/nrm2236 (Pubitemid 47462131)
34. Bouxsein M. L., Boyd S. K., Christiansen B. A., Guldberg R. E., Jepsen K. J., Müller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. Journal of Bone and Mineral Research 2010 25 7 1468 1486 2-s2.0-77954756294 10.1002/jbmr.141
35. Hatch N. E., Li Y., Franceschi R. T., FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2. Journal of Bone and Mineral Research 2009 24 4 652 662 2-s2.0-65549107318 10.1359/jbmr.081213
36. Krebsbach P. H., Gu K., Franceschi R. T., Rutherford R. B., Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Human Gene Therapy 2000 11 8 1201 1210 2-s2.0-0034690624 10.1089/10430340050015248 (Pubitemid 30331585)
37. Perlyn C. A., DeLeon V. B., Babbs C., Govier D., Burell L., Darvann T., Kreiborg S., Morriss-Kay G., The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional microCT. Cleft Palate-Craniofacial Journal 2006 43 6 740 747 2-s2.0-33751228726 10.1597/05-212 (Pubitemid 44788781)
38. Birgersdotter A., Sandberg R., Ernberg I., Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems. Seminars in Cancer Biology 2005 15 5 405 412 2-s2.0-23744472983 10.1016/j.semcancer.2005.06. 009 (Pubitemid 41140308)
39. Gurkan U. A., Kishore V., Condon K. W., Bellido T. M., Akkus O., A scaffold-free multicellular three-dimensional in vitro model of osteogenesis. Calcified Tissue International 2011 88 5 388 401 2-s2.0-79955627807 10.1007/s00223-011-9467-3
40. Baraniak P. R., McDevitt T. C., Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell and Tissue Research 2012 347 3 701 711 2-s2.0-79961141891 10.1007/s00441-011-1215-5
41. Murshed M., Harmey D., Millán J. L., McKee M. D., Karsenty G., Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes and Development 2005 19 9 1093 1104 2-s2.0-18244392685 10.1101/gad.1276205 (Pubitemid 40632454)
42. Chen L., Li D., Li C., Engel A., Deng C. X., A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 2003 33 2 169 178 2-s2.0-0141678494 10.1016/S8756-3282(03)00222-9 (Pubitemid 37117129)
43. P244R mouse, a genetic model for the muenke craniosynostosis syndrome. Developmental Dynamics 2009 238 2 331 342 2-s2.0-57749100685 10.1002/dvdy.21790
44. Komatsu Y., Yu P. B., Kamiya N., Pan H., Fukuda T., Scott G. J., Ray M. K., Yamamura K. I., Mishina Y., Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice. Journal of Bone and Mineral Research 2012 10.1002/jbmr.1857
45. Holmes G., Rothschild G., Roy U. B., Deng C. X., Mansukhani A., Basilico C., Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Developmental Biology 2009 328 2 273 284 2-s2.0-63349106487 10.1016/j.ydbio.2009.01.026
46. Yin L., Du X., Li C., Xu X., Chen Z., Su N., Zhao L., Qi H., Li F., Xue J., Yang J., Jin M., Deng C., Chen L., A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Bone 2008 42 4 631 643 2-s2.0-40949140612 10.1016/j.bone.2007.11.019
47. Zhou Y. X., Xu X., Chen L., Li C., Brodie S. G., Deng C. X., A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Human Molecular Genetics 2000 9 13 2001 2008 2-s2.0-0034641606 (Pubitemid 30642665)
48. Fragale A., Tartaglia M., Bernardini S., Di Stasi A. M. M., Di Rocco C., Velardi F., Teti A., Battaglia P. A., Migliaccio S., Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. American Journal of Pathology 1999 154 5 1465 1477 2-s2.0-0032934535 (Pubitemid 29226442)
49. Mansukhani A., Bellosta P., Sahni M., Basilico C., Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. Journal of Bone and Mineral Research 2000 149 1297 1308 (Pubitemid 30399682)
50. Online Mendelian Inheritance in Man, OMIM, MIM Number 307800 Baltimore, Md, USA Johns Hopkins University. 2011, http://omim.org/entry/307800
51. Roy W. A., Iorio R. J., Meyer G. A., Craniosynostosis in vitamin D-resistant rickets. A mouse model. Journal of Neurosurgery 1981 55 2 265 271 2-s2.0-0019441502 (Pubitemid 11034241)
52. Sabbagh Y., Jones A. O., Tenenhouse H. S., PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Human Mutation 2000 16 1 6 (Pubitemid 30447960)
53. Liang G., Katz L. D., Insogna K. L., Carpenter T. O., MacIca C. M., Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcified Tissue International 2009 85 3 235 246 2-s2.0-69549086356 10.1007/s00223-009-9270-6
54. Online Mendelian Inheritance in Man, OMIM, MIM Number 171760 Baltimore, Md, USA Johns Hopkins University. 2009, http://omim.org/entry/171760
55. Wenkert D., Benigno M., Mack K., McAlister W., Mumm S., Whyte M., Hypophosphatasia: prevalence of clinical problems in 175 pediatric patients. Proceedings of the American Society for Bone and Mineral Research 31st Annual Meeting 2009 Denver, Colo, USA. Abstract A09001674
56. Whyte M. P., Physiological role of alkaline phosphatase explored in hypophosphatasia. Annals of the New York Academy of Sciences 2010 1192 190 200 2-s2.0-77950665927 10.1111/j.1749-6632.2010.05387.x
57. Mornet E., Hypophosphatasia. Orphanet Journal of Rare Diseases 2007 2 40
58. Narisawa S., Fröhlander N., Millán J.L., Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasi. Developmental Dynamics 1997 208 432 446 (Pubitemid 27114295)
59. Shetty A. K., Thomas T., Rao J., Vargas A., Rickets and secondary craniosynostosis associated with long-term antacid use in an infant. Archives of Pediatrics and Adolescent Medicine 1998 152 12 1243 1245 2-s2.0-0031794766 (Pubitemid 28558116)